<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016228"><a href="http://purl.obolibrary.org/obo/MONDO_0016228">MONDO:0016228</a></h3>
<p><strong>Label:</strong> rare vascular tumor</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018049">MONDO:0018049</a> (Kaposi sarcoma), <a href="http://purl.obolibrary.org/obo/MONDO_0016223">MONDO:0016223</a> (infantile hemangioma of rare localization), <a href="http://purl.obolibrary.org/obo/MONDO_0016982">MONDO:0016982</a> (angiosarcoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0018718">MONDO:0018718</a> (vascular tumor with associated anomalies), <a href="http://purl.obolibrary.org/obo/MONDO_0018715">MONDO:0018715</a> (congenital hemangioma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_148000">OMIM:148000</a>, <a href="http://www.orpha.net/ORDO/Orphanet_263413">Orphanet:263413</a>, <a href="http://www.orpha.net/ORDO/Orphanet_458827">Orphanet:458827</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33276">Orphanet:33276</a>, <a href="http://www.orpha.net/ORDO/Orphanet_210589">Orphanet:210589</a>, <a href="http://www.orpha.net/ORDO/Orphanet_458775">Orphanet:458775</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) 57.49%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000969">HP:0000969</a> (Edema) and <a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 57.49%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) 52.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000969">HP:0000969</a> (Edema) and <a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) 52.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 39.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) 31.10%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007400">HP:0007400</a> (Irregular hyperpigmentation) 27.99%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) 24.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000969">HP:0000969</a> (Edema) 22.66%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011032">HP:0011032</a> (Abnormality of fluid regulation) 22.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001000">HP:0001000</a> (Abnormality of skin pigmentation) 21.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011355">HP:0011355</a> (Localized skin lesion) 20.58%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) 19.04%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin) 18.91%</li>
</ul>
</body>
</html>
